July 16 (Reuters) - AstraZeneca ( AZN ) on Wednesday said that its experimental therapy anselamimab did not meet the main goal of a late-stage study for the treatment of AL amyloidosis, a rare condition that causes a buildup of protein deposits in the body. The primary outcome of the study was being measured as a combination of how long...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

ROME, July 16 (Reuters) - Carmaker Stellantis said on Wednesday it would discontinue its hydrogen fuel cell technology programme and no longer launch a range of hydrogen-powered vehicles this year, as it sees no development of the market in the mid-term. The group said the decision was due to the limited availability of hydrogen refuelling infrastructure, high capital requirements and...

ROME (Reuters) - Carmaker Stellantis said on Wednesday it would discontinue its hydrogen fuel cell technology programme and no longer launch a range of hydrogen-powered vehicles this year, as it sees no development of the market in the mid-term. The group said the decision was due to the limited availability of hydrogen refuelling infrastructure, high capital requirements and the need...